These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 624850)

  • 41. [Episodes of fever in the agranulocytic phase of the treatment of acute myeloblastic leukemia in adults].
    Bernard JF; Renoux M; Boivin P
    Sem Hop; 1976 Jan; 52(2):111-3. PubMed ID: 185700
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Review of amikacin usage in the EORTC trials.
    Zinner SH
    Am J Med; 1985 Jul; 79(1A):17-20. PubMed ID: 3895903
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship of fever, granulocytopenia and antimicrobial therapy to bacteremia in cancer patients.
    Gill FA; Robinson R; Maclowry JD; Levine AS
    Cancer; 1977 Apr; 39(4):1704-9. PubMed ID: 856452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer International Antimicrobial Therapy Cooperative Group.
    Meunier F; Zinner SH; Gaya H; Calandra T; Viscoli C; Klastersky J; Glauser M
    Antimicrob Agents Chemother; 1991 May; 35(5):873-8. PubMed ID: 1854169
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Empiric antimicrobial therapy in the febrile granulocytopenic patient.
    Hughes WT
    Infect Control Hosp Epidemiol; 1990 Mar; 11(3):151-6. PubMed ID: 2179402
    [No Abstract]   [Full Text] [Related]  

  • 46. Empiric antibiotic therapy.
    Schimpff SC; Aisner J
    Cancer Treat Rep; 1978 May; 62(5):673-80. PubMed ID: 350396
    [No Abstract]   [Full Text] [Related]  

  • 47. Antibacterial therapy--special considerations in neutropenic patients.
    Rodriguez V; Bodey GP
    Clin Haematol; 1976 Jun; 5(2):347-60. PubMed ID: 181192
    [No Abstract]   [Full Text] [Related]  

  • 48. Antibiotic therapy for the febrile granulocytopenic cancer patient: combination therapy vs. monotherapy.
    Wade JC
    Rev Infect Dis; 1989; 11 Suppl 7():S1572-81. PubMed ID: 2690295
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic therapy in cancer patients with fever and neutropenia.
    N Engl J Med; 1987 Feb; 316(7):410-2. PubMed ID: 3543678
    [No Abstract]   [Full Text] [Related]  

  • 50. Management of the febrile neutropenic patient.
    Mandell LA
    Can Med Assoc J; 1983 Apr; 128(8):915-7. PubMed ID: 6831337
    [No Abstract]   [Full Text] [Related]  

  • 51. Cefoperazone plus tobramycin versus ticarcillin plus tobramycin in febrile granulocytopenic cancer patients.
    Gucalp R; Lia S; McKitrick JC; Wiernik PH
    Am J Med; 1988 Jul; 85(1A):31-5. PubMed ID: 3041816
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Infectious episodes in granulocytopenic patients with acute myeloid leukaemia. Analysis of the prognostic factors in 99 cases (author's transl)].
    Lahuerta Palacios JJ; Larregla Garraus S; Santesmases Mestre M; García Marcilla A; Montero Castillo J
    Sangre (Barc); 1979; 24(5B):868-77. PubMed ID: 293930
    [No Abstract]   [Full Text] [Related]  

  • 53. Role of antimicrobial synergism in infected granulocytopenic patients.
    Standiford HC; Johnson DE; Schimpff SC
    Eur J Cancer Clin Oncol; 1984 Aug; 20(8):1007-10. PubMed ID: 6540682
    [No Abstract]   [Full Text] [Related]  

  • 54. Empirical antibiotic therapy in febrile patients with neutropenia and malignant disease.
    Tattersall MH; Hutchinson RM; Gaya H; Spiers AS
    Eur J Cancer (1965); 1973 Jun; 9(6):417-23. PubMed ID: 4372049
    [No Abstract]   [Full Text] [Related]  

  • 55. Prospective comparative trial of short course (four day) and continuous tobramycin in combination with cefoperazone or mezlocillin in febrile, granulocytopenic patients.
    Pegram PS; Phair JP; McMahan R; Murphy RL; Gordon LI; Washton H; Faubion C; Saviteer S; Cohen MS
    J Antimicrob Chemother; 1989 Oct; 24(4):591-604. PubMed ID: 2693432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Advances in the epidemiology of infection in the granulocytopenic patient (author's transl)].
    Garau Alemany J
    Sangre (Barc); 1979; 24(5B):836-44. PubMed ID: 524230
    [No Abstract]   [Full Text] [Related]  

  • 57. Infectious episodes in severely granulocytopenic patients.
    van der Meer JW; Alleman M; Boekhout M
    Infection; 1979; 7(4):171-5. PubMed ID: 511334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. After empiric therapy: what to do until the granulocyte comes back.
    Pizzo PA
    Rev Infect Dis; 1987; 9(1):214-9. PubMed ID: 3547574
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Empirical antibiotic therapy in the febrile neutropenic cancer patient: clinical efficacy and impact of monotherapy.
    Hathorn JW; Rubin M; Pizzo PA
    Antimicrob Agents Chemother; 1987 Jul; 31(7):971-7. PubMed ID: 3310871
    [No Abstract]   [Full Text] [Related]  

  • 60. Fever and fever management among intensive care patients with known or suspected infection: a multicentre prospective cohort study.
    Young P; Saxena M; Eastwood GM; Bellomo R; Beasley R
    Crit Care Resusc; 2011 Jun; 13(2):97-102. PubMed ID: 21627577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.